Skip to main content
. 2025 Sep 9;26(18):8778. doi: 10.3390/ijms26188778
SHCBP1 SHC SH2-domain binding protein 1
mPAL Murine protein of activated lymphocytes
NSCLC Non-small cell lung carcinoma
HCC Hepatocellular carcinoma
CDK Cyclin-dependent kinase
EMT Epithelial–mesenchymal transition
PbH1 Parallel beta-helix
PLK1 Polo-like kinase 1
EGF Epidermal growth factor
TGF-β Transforming growth factor β
MiRNA MicroRNA
LncRNA Long noncoding RNA
CeRNA Competing endogenous RNA
AURKB Aurora kinase B
FGF Fibroblast growth factor
USP49 Ubiquitin-specific peptidase 49
CBP CREB binding protein
HNSCC Head and neck squamous cell carcinoma
VEGF Vascular endothelial growth factor
RTK Receptor tyrosine kinase
PDAC Pancreatic ductal adenocarcinoma
EOGT EGF domain specific O-linked GlcNActransferase
TME Tumor microenvironment
TAM Tumor-associated macrophage
TMB Tumor mutation burden
MSI Microsatellite instability
CAG Cancer–associated fibroblast
ICI Immune checkpoint inhibitor
PPI Protein–protein interaction
SCLC Small cell lung cancer
RNAi RNA interference
SiRNA Small interfering RNA
ShRNA Short hairpin RNA
TFBG Theaflavin-3,3′-digallate